Cannabis for Parkinson’s disease
Parkinson’s disease (PD), a progressive neurodegenerative disorder, primarily affects the central nervous system, which controls a multitude of our body’s functions. It is characterized by distinctive motor symptoms such as tremors, where the individual experiences shaking in the hands, limbs, or head; rigidity, which manifests as stiffness or inflexibility in the muscles; and bradykinesia, the slowness of voluntary movement. Moreover, PD patients often face challenges in maintaining balance and posture, making it a hazardous condition that can lead to falls and associated injuries. However, Parkinson’s disease is not limited to these motor symptoms. It can also cause numerous non-motor symptoms, transforming it into a multifaceted medical condition. These can encompass sleep disturbances like insomnia or REM sleep behavior disorder, cognitive impairment ranging from mild cognitive decline to severe dementia, and psychological issues such as depression and anxiety. In essence, Parkinson’s disease has a broad-spectrum impact, affecting various aspects of an individual’s life. Recent medical advancements have shed light on the potential benefits of medical cannabis for Parkinson’s disease patients. Medical cannabis, extracted from the Cannabis sativa or Cannabis indica plant, contains active compounds like cannabinoids that have been shown to improve the quality of life for those living with PD. Medical cannabis has been credited with reducing key motor symptoms, such as the debilitating tremors and rigidity that are emblematic of the disease. This can help restore some level of independence to the patient, making their day-to-day life more manageable. Additionally, medical cannabis has potential benefits that extend beyond motor symptom management. It has been identified as a possible aid in improving sleep quality, a significant concern for PD patients grappling with sleep disturbances. Also, it may help alleviate anxiety and depression, both common psychological complications in Parkinson’s disease. Some studies have also pointed towards its potential to enhance cognitive function, which can be a ray of hope for those dealing with cognitive impairment due to the disease. In a recent study published in the Journal of Parkinson’s Disease, researchers at the University of Tel Aviv in Israel found that medical cannabis was efficient in enhancing the quality of life in Parkinson’s disease patients. The study illuminated that PD patients who used medical cannabis experienced improvements in their mood, sleep quality, and ability to perform activities of daily living, vital components of overall quality of life. The research also underscored that medical cannabis was well-tolerated by patients and did not trigger any severe side effects, marking it as a relatively safe option. This study is not an isolated instance. A 2021 review of 10 research studies found similar results, further substantiating the potential benefits of medical cannabis for Parkinson’s disease patients. The review echoed the previous findings that medical cannabis was safe, well-tolerated, and effective in improving their quality of life. Another 2021 review, this one of 11 studies, corroborated these findings, stating that medical cannabis was instrumental in improving both motor and non-motor symptoms, consequently enhancing the overall quality of life for PD patients. The cumulative research suggests that medical cannabis emerges as a safe and effective treatment for enhancing the quality of life in Parkinson’s disease patients. However, while the current evidence is promising and indicative of its potential benefits, more comprehensive research is required to fully grasp the long-term safety and efficacy of medical cannabis for Parkinson’s disease. This will ensure that medical professionals can provide the best possible advice to their patients, and patients can make informed decisions about their treatment plans.
If you are a Parkinson’s disease patient and you are interested in trying medical cannabis, talk to your doctor. They can help you to determine if medical cannabis is right for you and can provide guidance on how to use it safely and effectively.
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that primarily affects the central nervous system, which controls a multitude of our body’s functions. It is characterized by distinctive motor symptoms such as tremors, rigidity, and bradykinesia. PD patients often face challenges in maintaining balance and posture, making it a hazardous condition that can lead to falls and associated injuries. However, Parkinson’s disease is not limited to these motor symptoms. It can also cause numerous non-motor symptoms, transforming it into a multifaceted medical condition. These can encompass sleep disturbances like insomnia or REM sleep behavior disorder, cognitive impairment ranging from mild cognitive decline to severe dementia, and psychological issues such as depression and anxiety. In essence, Parkinson’s disease has a broad-spectrum impact, affecting various aspects of an individual’s life.
Medical cannabis, extracted from the Cannabis sativa or Cannabis indica plant, contains active compounds like cannabinoids that have been shown to improve the quality of life for those living with PD. Medical cannabis has been credited with reducing key motor symptoms, such as the debilitating tremors and rigidity that are emblematic of the disease. This can help restore some level of independence to the patient, making their day-to-day life more manageable. Additionally, medical cannabis has potential benefits that extend beyond motor symptom management. It has been identified as a possible aid in improving sleep quality, a significant concern for PD patients grappling with sleep disturbances. Also, it may help alleviate anxiety and depression, both common psychological comorbidities of PD 123.
It is important to note that the use of medical cannabis for PD treatment is not yet widely accepted. In the UK, medical cannabis can be considered for PD treatment when current first-line therapies are ineffective at managing symptoms 4.
1: Journal of Affective Disorders 2: Frontiers in Psychiatry 3: Parkinson’s Foundation 4: Leafie
Learn more:
1. parkinson.org2. goodrx.com3. parkinson.org4. verywellhealth.com